Terminated × Neoplasms, Germ Cell and Embryonal × Clear all
NCT02859415 2022-04-05

Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
3 enrolled 10 charts
NCT01215578 2015-04-30

NET

Assistance Publique - Hôpitaux de Paris

Phase 2 Terminated
33 enrolled